JPWO2019241503A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019241503A5 JPWO2019241503A5 JP2020569002A JP2020569002A JPWO2019241503A5 JP WO2019241503 A5 JPWO2019241503 A5 JP WO2019241503A5 JP 2020569002 A JP2020569002 A JP 2020569002A JP 2020569002 A JP2020569002 A JP 2020569002A JP WO2019241503 A5 JPWO2019241503 A5 JP WO2019241503A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- aminosterol
- pharmaceutical composition
- subject
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862684496P | 2018-06-13 | 2018-06-13 | |
| US62/684,496 | 2018-06-13 | ||
| PCT/US2019/036946 WO2019241503A1 (en) | 2018-06-13 | 2019-06-13 | Methods and compositions for treating and/or preventing the progression and/or onset of age-related neurodegeneration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021527090A JP2021527090A (ja) | 2021-10-11 |
| JPWO2019241503A5 true JPWO2019241503A5 (ko) | 2022-04-22 |
Family
ID=68838925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020569002A Pending JP2021527090A (ja) | 2018-06-13 | 2019-06-13 | 老化関連神経変性の進行および／または発症を治療および／または予防するための方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20210252023A1 (ko) |
| EP (1) | EP3806862A4 (ko) |
| JP (1) | JP2021527090A (ko) |
| KR (1) | KR20210009422A (ko) |
| CN (1) | CN112566641A (ko) |
| AU (1) | AU2019285065A1 (ko) |
| BR (1) | BR112020025296A2 (ko) |
| CA (1) | CA3103463A1 (ko) |
| MX (1) | MX2020013614A (ko) |
| SG (1) | SG11202012343TA (ko) |
| WO (1) | WO2019241503A1 (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11464789B2 (en) | 2018-08-03 | 2022-10-11 | Enterin, Inc. | Aminosterol compositions and methods of using the same for treating schizophrenia |
| US20210260078A1 (en) * | 2018-08-03 | 2021-08-26 | Philadelphia | Low dosage intranasal aminosterol dosage forms and methods of using the same |
| EP3829587A4 (en) * | 2018-08-03 | 2022-07-20 | Enterin, Inc. | COMPOSITIONS AND METHODS FOR TREATING GUT-BRAIN AXIS DISORDERS |
| CN110827282B (zh) * | 2020-01-13 | 2020-04-10 | 南京慧脑云计算有限公司 | 一种基于磁共振成像的脑白质纤维束示踪分析方法及系统 |
| CN111110873A (zh) * | 2020-02-24 | 2020-05-08 | 苏州欣影生物医药技术有限公司 | 一种磁共振/核医学双模态分子影像探针的制备方法 |
| CN111528839B (zh) * | 2020-05-29 | 2023-06-23 | 北京京东方健康科技有限公司 | 睡眠检测方法和装置、助眠设备和方法 |
| JP2024519927A (ja) * | 2021-05-21 | 2024-05-21 | アニマスキュア インコーポレイテッド． | イノトジオールを含む筋疾患の予防または治療用組成物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6143738A (en) * | 1995-06-07 | 2000-11-07 | Magainin Pharmaceuticals, Inc. | Therapeutic uses for an aminosterol compound |
| CA2922021C (en) * | 2007-09-06 | 2018-01-09 | Ohr Pharmaceutical, Inc. | A method for treating diabetes |
| US8623416B2 (en) * | 2009-11-25 | 2014-01-07 | Michael Zasloff | Formulations comprising aminosterols |
| US10040817B2 (en) * | 2013-10-03 | 2018-08-07 | Enterin Laboratories, Inc. | Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same |
-
2019
- 2019-06-13 AU AU2019285065A patent/AU2019285065A1/en active Pending
- 2019-06-13 MX MX2020013614A patent/MX2020013614A/es unknown
- 2019-06-13 JP JP2020569002A patent/JP2021527090A/ja active Pending
- 2019-06-13 KR KR1020217000559A patent/KR20210009422A/ko not_active Application Discontinuation
- 2019-06-13 BR BR112020025296-4A patent/BR112020025296A2/pt unknown
- 2019-06-13 US US17/251,322 patent/US20210252023A1/en active Pending
- 2019-06-13 US US16/440,414 patent/US20190381071A1/en not_active Abandoned
- 2019-06-13 WO PCT/US2019/036946 patent/WO2019241503A1/en unknown
- 2019-06-13 CN CN201980052151.2A patent/CN112566641A/zh active Pending
- 2019-06-13 CA CA3103463A patent/CA3103463A1/en active Pending
- 2019-06-13 SG SG11202012343TA patent/SG11202012343TA/en unknown
- 2019-06-13 EP EP19818961.5A patent/EP3806862A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527090A (ja) | 老化関連神経変性の進行および／または発症を治療および／または予防するための方法および組成物 | |
| JP2022003085A (ja) | 神経変性疾患のための治療薬 | |
| JP7352542B2 (ja) | 運動失調を処置するためのリルゾールプロドラッグの使用 | |
| US20230123701A1 (en) | Human aminosterol ent-03 compounds, related compositions comprising the same, and methods of using the same | |
| US20230372335A1 (en) | TREATMENT OF COGNITIVE IMPAIRMENT WITH A CNS-PENETRANT sGC STIMULATOR | |
| EP3829587A1 (en) | Compositions and methods for treating brain-gut disorders | |
| JPWO2019241503A5 (ko) | ||
| Nicoletti et al. | Treatment with dimethyl fumarate enhances cholinergic transmission in multiple sclerosis | |
| US20210260078A1 (en) | Low dosage intranasal aminosterol dosage forms and methods of using the same | |
| US20200038420A1 (en) | Aminosterol compositions and methods of using the same for treating depression | |
| CN116134048A (zh) | 用于治疗神经精神障碍的组合物和方法 | |
| De Pasqua | Myotonic syndromes: analysis of factors with pathogenetic and prognostic significance | |
| WO2019226080A1 (en) | A drug for treating disorders of an organ or tissue function and diseases accompanied by such disorders, and the method for obtaining it | |
| US20210315907A1 (en) | Compositions and methods for treating brain-gut disorders | |
| EP4376954A1 (en) | Lemborexant for use in methods of treating irregular sleep-wake rhythm disorder and circadian rhythm sleep disorders associated with neurodegenerative diseases | |
| US20050233976A1 (en) | Therapeutic methods | |
| WO2023239908A1 (en) | Treatment of mitochondrial diseases with the cns-penetrant sgc stimulator zagociguat | |
| Eeg-Olofsson | Dystrophinopathies | |
| Byrne et al. | Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy |